Hematopoetic stem cells for treatment of neuromyelitis optica
The aim of this trial is to assess the safety and efficacy of intravenous infusion of autologous hematopoietic stem cells in patients with neuromyelitis optica.
Read More
Product Information for
Hematopoetic stem cells for treatment of neuromyelitis optica